Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Use of a commercial enzyme immunoassay to monitor dengue virus replication in cultured cells

Authors: Juan E Ludert, Clemente Mosso, Ivonne Ceballos-Olvera, Rosa M del Angel

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Current methods for dengue virus quantitation are either time consuming, technically demanding or costly. As an alternative, the commercial enzyme immunoassay Platelia™ Dengue NS1 AG (Bio-Rad Laboratories) was used to monitor semiquantitatively dengue virus replication in cultured cells. The presence of NS1 protein was evaluated in supernatants from Vero and C6/36 HT cells infected with dengue virus. The amount of NS1 detected in the supernatants of infected cells was proportional to the initial MOI used and to the time of post infection harvest. This immunoassay was also able to detect the presence of NS1 in the supernatants of infected human macrophages. Inhibition of dengue virus replication in C6/36 HT cells treated with lysosomotropic drugs was readily monitored with the use of this assay. These results suggest that the Platelia™ Dengue NS1 AG kit can be used as a fast and reliable surrogate method for the relative quantitation of dengue virus replication in cultured cells.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lindenbach BD, Rice CM: Flaviviridae : the virus and their replication. In Virology. Edited by: Fields BN. Lippincott-Raven, Philadelphia, PA; 2001:991-1042. Lindenbach BD, Rice CM: Flaviviridae : the virus and their replication. In Virology. Edited by: Fields BN. Lippincott-Raven, Philadelphia, PA; 2001:991-1042.
3.
go back to reference Malewicz B, Jenkin HM: Development of dengue virus plaques under serum-free overlay medium. J Clin Microbiol 1979, 9: 609-614.PubMedCentralPubMed Malewicz B, Jenkin HM: Development of dengue virus plaques under serum-free overlay medium. J Clin Microbiol 1979, 9: 609-614.PubMedCentralPubMed
4.
go back to reference Stim TB: Dengue virus plaque development in simian cell systems. I. Factors influencing virus absorption and variables in the agar overlay medium. Appl Microbiol 1970, 19: 751-756.PubMedCentralPubMed Stim TB: Dengue virus plaque development in simian cell systems. I. Factors influencing virus absorption and variables in the agar overlay medium. Appl Microbiol 1970, 19: 751-756.PubMedCentralPubMed
5.
go back to reference Houng HS, Chung-Ming Chen R, Vaughn DW, Kanesa-Thasan N: Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1–4 using conserved and serotype specific 3'noncoding sequences. J Virol Meth 2001, 95: 19-32. 10.1016/S0166-0934(01)00280-4CrossRef Houng HS, Chung-Ming Chen R, Vaughn DW, Kanesa-Thasan N: Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1–4 using conserved and serotype specific 3'noncoding sequences. J Virol Meth 2001, 95: 19-32. 10.1016/S0166-0934(01)00280-4CrossRef
6.
go back to reference Kong YY, Thai CH, Tin TC, Davi S: Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. J Virol Meth 2006, 138: 123-130. 10.1016/j.jviromet.2006.08.003CrossRef Kong YY, Thai CH, Tin TC, Davi S: Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. J Virol Meth 2006, 138: 123-130. 10.1016/j.jviromet.2006.08.003CrossRef
7.
go back to reference Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, Kalayanarooj S, Nisalak A, Norman JE, Ennis FA, Rothman AR: Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 2001, 63: 29-34. 10.1002/1096-9071(200101)63:1<29::AID-JMV1004>3.0.CO;2-SCrossRefPubMed Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, Kalayanarooj S, Nisalak A, Norman JE, Ennis FA, Rothman AR: Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 2001, 63: 29-34. 10.1002/1096-9071(200101)63:1<29::AID-JMV1004>3.0.CO;2-SCrossRefPubMed
8.
go back to reference Upanam S, Cabrera-Hernandez A, Ekkapongpisit M, Smith DR: A simplified PCR methodology for semiquantitatively analyzing dengue viruses. Jpn J Infect Dis 2006, 59: 383-387. Upanam S, Cabrera-Hernandez A, Ekkapongpisit M, Smith DR: A simplified PCR methodology for semiquantitatively analyzing dengue viruses. Jpn J Infect Dis 2006, 59: 383-387.
9.
go back to reference Wang WK, Lee CN, Kao CL, Lin YL, King CC: Quantitative competition reverse transcription-PCR for quantification of dengue virus RNA. J Clin Microbiol 2000, 38: 3306-3310.PubMedCentralPubMed Wang WK, Lee CN, Kao CL, Lin YL, King CC: Quantitative competition reverse transcription-PCR for quantification of dengue virus RNA. J Clin Microbiol 2000, 38: 3306-3310.PubMedCentralPubMed
10.
go back to reference Lambeth CR, White LJ, Johnston RE, de Silva AM: Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 2005, 43: 3267-3272. 10.1128/JCM.43.7.3267-3272.2005PubMedCentralCrossRefPubMed Lambeth CR, White LJ, Johnston RE, de Silva AM: Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 2005, 43: 3267-3272. 10.1128/JCM.43.7.3267-3272.2005PubMedCentralCrossRefPubMed
11.
go back to reference Payne AF, Binduga-Gajewska I, Kauffman EB, Kramer LD: Quantitation of flavivirus by fluoresce focus assay. J Virol Meth 2006, 134: 183-189. 10.1016/j.jviromet.2006.01.003CrossRef Payne AF, Binduga-Gajewska I, Kauffman EB, Kramer LD: Quantitation of flavivirus by fluoresce focus assay. J Virol Meth 2006, 134: 183-189. 10.1016/j.jviromet.2006.01.003CrossRef
12.
go back to reference Winkler G, Maxwell SE, Ruemmler C, Stoller V: Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 1989, 171: 302-305. 10.1016/0042-6822(89)90544-8CrossRefPubMed Winkler G, Maxwell SE, Ruemmler C, Stoller V: Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 1989, 171: 302-305. 10.1016/0042-6822(89)90544-8CrossRefPubMed
13.
go back to reference Lindenbach BD, Rice CM: Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 1997, 71: 9608-9617.PubMedCentralPubMed Lindenbach BD, Rice CM: Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 1997, 71: 9608-9617.PubMedCentralPubMed
14.
go back to reference Lindenbach BD, Rice CM: Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol 1999, 73: 4611-4621.PubMedCentralPubMed Lindenbach BD, Rice CM: Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol 1999, 73: 4611-4621.PubMedCentralPubMed
15.
go back to reference Muylaert IA, Chambers TJ, Galler R, Rice CM: Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology 1996, 222: 159-168. 10.1006/viro.1996.0406CrossRefPubMed Muylaert IA, Chambers TJ, Galler R, Rice CM: Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology 1996, 222: 159-168. 10.1006/viro.1996.0406CrossRefPubMed
16.
go back to reference Muylaert IR, Galler R, Rice CM: Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol 1997, 71: 291-298.PubMedCentralPubMed Muylaert IR, Galler R, Rice CM: Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J Virol 1997, 71: 291-298.PubMedCentralPubMed
17.
go back to reference Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V: Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 1999, 73: 6104-6110.PubMedCentralPubMed Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V: Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 1999, 73: 6104-6110.PubMedCentralPubMed
18.
go back to reference Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M: Enzyme-linked immunoassay specific to dengue virus type 1 non-structural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002, 40: 376-381. 10.1128/JCM.40.02.376-381.2002PubMedCentralCrossRefPubMed Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M: Enzyme-linked immunoassay specific to dengue virus type 1 non-structural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002, 40: 376-381. 10.1128/JCM.40.02.376-381.2002PubMedCentralCrossRefPubMed
19.
go back to reference Young PR, Hilditch PA, Bletchly C, Halloran W: An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000, 38: 1053-1057.PubMedCentralPubMed Young PR, Hilditch PA, Bletchly C, Halloran W: An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000, 38: 1053-1057.PubMedCentralPubMed
20.
go back to reference Dussart P, Labeau B, Lagathu G, Louis P, Nunes MRT, Rodrigues SG, Storck-Hermann C, Cesaire R, Morvan J, Flamand M, Baril L: Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vacc Immunol 2006, 13: 1185-1189. 10.1128/CVI.00229-06CrossRef Dussart P, Labeau B, Lagathu G, Louis P, Nunes MRT, Rodrigues SG, Storck-Hermann C, Cesaire R, Morvan J, Flamand M, Baril L: Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vacc Immunol 2006, 13: 1185-1189. 10.1128/CVI.00229-06CrossRef
21.
go back to reference Kumarasamy V, Chua SK, Hassan Z, Huahab AHA, Chem JK, Mohamad M, Chua KB: Evaluating the sensitivity of a commercial dengue NS1-antigen capture ELISA for early diagnosis for acute dengue virus infection. Singapore Med J 2007, 48: 669-673.PubMed Kumarasamy V, Chua SK, Hassan Z, Huahab AHA, Chem JK, Mohamad M, Chua KB: Evaluating the sensitivity of a commercial dengue NS1-antigen capture ELISA for early diagnosis for acute dengue virus infection. Singapore Med J 2007, 48: 669-673.PubMed
22.
go back to reference Modis Y, Ogata S, Clements D, Harrison SC: A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003, 100: 6986-6991. 10.1073/pnas.0832193100PubMedCentralCrossRefPubMed Modis Y, Ogata S, Clements D, Harrison SC: A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003, 100: 6986-6991. 10.1073/pnas.0832193100PubMedCentralCrossRefPubMed
23.
go back to reference Keelapang P, Sriburi R, Supasa S, Payadee N, Songjaeng A, Jairungsri A, Puttikhung C, Kasinrerk W, Malasit P, Sittisombut N: Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue virus. J Virol 2004, 78: 2367-2381. 10.1128/JVI.78.5.2367-2381.2004PubMedCentralCrossRefPubMed Keelapang P, Sriburi R, Supasa S, Payadee N, Songjaeng A, Jairungsri A, Puttikhung C, Kasinrerk W, Malasit P, Sittisombut N: Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue virus. J Virol 2004, 78: 2367-2381. 10.1128/JVI.78.5.2367-2381.2004PubMedCentralCrossRefPubMed
24.
go back to reference Leblois H, Young PR: Maturation of the dengue-2 virus NS1 protein in insect cells: effects of downstream NS2A sequences on baculovirus-expressed gene constructs. J Gen Virol 1995, 76: 979-984.CrossRefPubMed Leblois H, Young PR: Maturation of the dengue-2 virus NS1 protein in insect cells: effects of downstream NS2A sequences on baculovirus-expressed gene constructs. J Gen Virol 1995, 76: 979-984.CrossRefPubMed
25.
go back to reference Gould EA, Clegg JC: Growth, titration and purification of alphaviruses and flaviviruses. In Virology: a practical approach. Edited by: Mahy BWJ. IRL press, Oxford, U.K; 1991:43-78. Gould EA, Clegg JC: Growth, titration and purification of alphaviruses and flaviviruses. In Virology: a practical approach. Edited by: Mahy BWJ. IRL press, Oxford, U.K; 1991:43-78.
26.
go back to reference Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM: Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 2005, 79: 4557-4567. 10.1128/JVI.79.8.4557-4567.2005PubMedCentralCrossRefPubMed Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM: Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 2005, 79: 4557-4567. 10.1128/JVI.79.8.4557-4567.2005PubMedCentralCrossRefPubMed
Metadata
Title
Use of a commercial enzyme immunoassay to monitor dengue virus replication in cultured cells
Authors
Juan E Ludert
Clemente Mosso
Ivonne Ceballos-Olvera
Rosa M del Angel
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-51

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.